Jeanne Cunicelli

Jeanne Cunicelli is Executive Vice President at UPMC Enterprises. Leveraging the multifaceted resources of $21 billion world-renowned health care provider and insurer UPMC, Jeanne leads its Translational Sciences team that invests in, and supports the development and commercialization of, cutting-edge therapeutics, diagnostics, and integrated health care solutions.

They collaborate closely with scientist-entrepreneurs to invest in creation of new companies, as well as in building companies at all stages that are developing innovative products to fundamentally improve health care.

Since joining UPMC in 2017 and with the formation of the Immune Transplant and Therapy Center (ITTC), Jeanne has built a world-class team of highly-skilled investment and scientific experts, enabling the group to form five companies, invest over $200 million in life sciences, and support more than 40 research projects generated by the University of Pittsburgh. Jeanne leads UPMC’s effort to deploy $1 billion in life sciences innovations over the next five years, including continuing to strengthen the Translational Sciences portfolio. She is responsible for overseeing the review and due diligence of nearly 60 investment opportunities in the pipeline today. She currently serves on the boards of two portfolio companies, BlueSphere Bio and Generian, and is a member of the executive committee of the UPMC Genome Center.

Jeanne has more than two decades of experience as a life science venture capital investor and advisor. Prior to joining UPMC, she was a Managing Director and Investment Partner at Bay City Capital, where she lead and/or served on the Boards of Directors of IDev Technologies, Protez Pharmaceuticals, NuPathe, Inc., Calypso Medical, Oculex Pharmaceuticals, MAP Pharmaceuticals and Syntonix Therapeutics. Jeanne is a member of the Board of Trustees of Carnegie Mellon University, serving on the executive committee of the board, as the chairman of the compensation committee and as a member of the finance and audit committees. She received an MBA in Finance from the University of San Francisco and holds a B.A. degree in Cognitive Psychology from Carnegie Mellon University.